GVB Biopharma, a top provider of hemp and cannabinoid solutions, is introducing its new high-purity Cannabicitran (CBT) Isolate, adding to its selection of uncommon cannabinoid products.

PRINEVILLE, Ore., March 13, 2025 — GVB Biopharma, a leading creator, manufacturer, and worldwide distributor of cannabinoid products derived from hemp, is pleased to announce the release of its new CBT Isolate. This recent addition to their product line highlights GVB Biopharma’s dedication to innovation and quality by delivering sophisticated, pure, and reliable cannabinoid ingredients to customers globally.

CBT, or Cannabicitran, is a rare cannabinoid rapidly gaining traction in the hemp and wellness sectors. Similar to other uncommon cannabinoids, CBT exhibits unique attributes and potential advantages for consumers seeking novel functional product formulations. Produced to strict standards through comprehensive in-house testing and a commitment to quality assurance, GVB Biopharma’s CBT Isolate is suitable for use in various applications, including tinctures, topicals, and edibles.

According to Drew Spiegel, CEO of GVB Biopharma, “The launch of our CBT Isolate highlights our commitment to being an industry leader in both quality and innovation. Rare cannabinoids are driving new product development, and GVB Biopharma aims to provide our clients with the finest, high-purity ingredients necessary for creating unique and effective formulations.”

Key Benefits and Features of GVB Biopharma’s CBT Isolate

• High Purity: Manufactured using cutting-edge extraction and refinement techniques under strict quality controls.
• Reliable Consistency: Certified manufacturing processes at GVB Biopharma ensure consistent quality and potency in every batch.
• Versatile Applications: Well-suited for diverse product types, such as oils, beverages, supplements, and topical treatments.
• Exceptional Quality Assurance: Supported by thorough testing, transparent Certificates of Analysis (COAs), and expert assistance.

Jack Feldman, President of GVB Biopharma, stated, “The introduction of CBT Isolate allows our clients to stay ahead in the rapidly changing cannabinoid market. We eagerly anticipate seeing how brands integrate CBT into their product development and how it expands the potential of cannabinoid formulations.”

GVB Biopharma’s addition of CBT Isolate to its wide range of products reinforces its standing as a reliable partner for businesses in search of premium, innovative solutions derived from hemp. The launch demonstrates GVB Biopharma’s commitment to providing brands with the resources and knowledge needed to develop unique consumer experiences in the vibrant cannabis and wellness industries.

Visit the for further details on GVB Biopharma’s CBT Isolate or to place an order.

About GVB Biopharma
GVB Biopharma is a leading developer, manufacturer, and global distributor of products based on hemp and cannabinoids. Utilizing advanced extraction technologies, rigorous testing procedures, and strong quality assurance protocols, GVB Biopharma offers a complete range of solutions. The company’s continuous focus on innovation, compliance, and customer satisfaction distinguishes it as a trusted partner in the worldwide cannabinoid market.

For media inquiries, please contact:
Gabi de la Guardia

SOURCE GVB Biopharma

“`